Fundraising Fox
🦊/People
Sign in

Jonathan Hepple

Investor

Managing Partner at Rosetta Capital Ltd. · Strategic Advisor at Oxford Science Enterprises

London, England, United Kingdom

Find your path to Jonathan

451 people in our graph share verified history with Jonathan — schools, employers, funds. One of them is your warm intro.

Dominic JacquessonunlockedJonathan: together at University of Oxford (1989–1992)
×6Jonathan: together at University of Cambridge
×5Jonathan: together at University of Oxford

About

Jon Hepple is a co-founder of Rosetta Capital with over 20 years of investment experience in life sciences. He began his investment career at Rothschild Asset Management and was later a partner at Seroba Life Sciences, where he held board seats at Covagen and Opsona. He is a Senior Advisor to Oxford Science Enterprises and holds a PhD from Cambridge University.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. Eyesense AGNon Executive Directorcurrent2024 — present
  2. Nucleome TherapeuticsNon Executive Directorcurrent2020 — present
  3. Carrick TherapeuticsNon Executive Directorcurrent2021 — present
  4. Mission TherapeuticsNon Executive Directorcurrent2021 — present
  5. Rosetta CapitalFounder & Directorcurrent2009 — present
  6. Oxford Science EnterprisesStrategic Advisorcurrent2020 — present
  7. Aprea ABNon-Executive Director2015 — 2020Stockholm, Sweden
  8. Clanotech ABNon-Executive Director2013 — 2020
  9. NovimmuneNon-Executive Director2014 — 2016
  10. ProCertus BioPharm Inc.Non-Executive Director2014 — 2015
  11. Axelar ABNon-Executive Director2013 — 2015
  12. Opsona TherapeuticsNon-Executive Director2012 — 2013
  13. Covagen AGNon-Executive Director2010 — 2013
  14. Seroba-Kernel Life SciencesPartner2009 — 2013
  15. BioScience Managers LtdFounder & Director2001 — 2008
  16. Rothschild Asset ManagementInvestment Analyst1998 — 2000
  17. ICRFPh.D student1993 — 1998Cambridge University

Skills & more

Start-ups25Venture Capital87Biotechnology39Lifesciences47Drug Discovery21Valuation4Investments33Licensing3Patents1Pharmaceutical Industry36R&D5Biopharmaceuticals24
+10 moreTechnology TransferJoint VenturesNon-Executive DirectorMedical DevicesCorporate DevelopmentScienceCommercializationMarket AnalysisStrategyIntellectual Property

From Jonathan's professional profile.

Investments

Board seats

Aprea TherapeuticsCarrick TherapeuticsCatalyst BiosciencesCovagenGlycoMimeticsMission TherapeuticsNovimmuneNucleome TherapeuticsOpsonaParatekTranzyme

Per the firm's website.

Colleagues at Rosetta Capital Ltd.

Donovan Leung
Investment Manager at Rosetta Capital Ltd.
Graham Fagg
Partner Emeritus at Rosetta Capital Ltd.
Ken MacLeod
Partner at Rosetta Capital Ltd.
Matthew James
Chief Financial Officer at Rosetta Capital Ltd.
Michael Forer
Partner at Rosetta Capital Ltd.
Namrata Turaga
Investment Manager at Rosetta Capital Ltd.
Torsten Goesch
Director at Rosetta Capital Ltd.

Frequently asked questions

Who is Jonathan Hepple?
Jon Hepple is a co-founder of Rosetta Capital with over 20 years of investment experience in life sciences. He began his investment career at Rothschild Asset Management and was later a partner at Seroba Life Sciences, where he held board seats at Covagen and Opsona. He is a Senior Advisor to Oxford Science Enterprises and holds a PhD from Cambridge University.
Where does Jonathan Hepple work?
Jonathan Hepple is Managing Partner at Rosetta Capital Ltd..
What does Jonathan Hepple invest in?
Jonathan Hepple invests in Biotech.
What boards does Jonathan Hepple sit on?
Jonathan Hepple holds tracked board seats at Aprea Therapeutics, Carrick Therapeutics, Catalyst Biosciences, Covagen, GlycoMimetics, Mission Therapeutics, Novimmune, Nucleome Therapeutics, Opsona, Paratek.
Where did Jonathan Hepple go to school?
Jonathan Hepple studied at University of Cambridge (PhD, Cancer Research); University of Oxford (Biology).

Same school

Shared employers